A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer

被引：0
|
作者：
Burzykowski, T
Piccart, MJ
Sledge, G
Carmichael, J
Luck, HJ
Mackey, JR
Nabholtz, JM
Paridaens, R
Biganzoli, L
Jassem, J
Blohmer, JU
Bontenbal, M
Bonneterre, J
Chan, S
Atalay, G
Therasse, P
Buyse, M
机构：
[1] Limburgs Univ Centrum, Diepenbeek, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
[3] IDDI, Brussels, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 50 条
  • [1] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [2] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [3] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [4] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [5] Evaluation of Overall Response Rate and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Immunotherapy Trials
    Mushti, Sirisha L.
    Mulkey, Flora
    Sridhara, Rajeshwari
    CLINICAL CANCER RESEARCH, 2018, 24 (10) : 2268 - 2275
  • [6] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [7] Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC).
    Sjoquist, Katrin Marie
    Lee, Chee
    Lord, Sally
    Chatfield, Mark D.
    Friedlander, Michael
    Simes, John
    Marschner, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
    Yoshihiro Matsubara
    Satomi Sakabayashi
    Tsutomu Nishimura
    Takanori Ishida
    Noriaki Ohuchi
    Satoshi Teramukai
    Masanori Fukushima
    International Journal of Clinical Oncology, 2011, 16 : 623 - 629
  • [9] Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
    Matsubara, Yoshihiro
    Sakabayashi, Satomi
    Nishimura, Tsutomu
    Ishida, Takanori
    Ohuchi, Noriaki
    Teramukai, Satoshi
    Fukushima, Masanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 623 - 629
  • [10] Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression-Free Survival on First-Line Therapy Predicts Overall Survival Impact
    Rayson, Daniel
    Lutes, Sarah
    Walsh, Gordon
    Sellon, Marlene
    Colwell, Bruce
    Dorreen, Mark
    Drucker, Arik
    Jeyakumar, Alwin
    Younis, Tallal
    BREAST JOURNAL, 2014, 20 (04): : 408 - 413
12345